Drug Search Results
More Filters [+]

Lonaprisan

Alternative Names: lonaprisan
Latest Update: 2014-10-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lonaprisan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Breast Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT00555919

P2

Completed

Breast Cancer

2010-04-01

Recent News Events

Date

Type

Title